Zenflow
YC W15San Francisco, US · Founded 2014 · Delaware corporation · 18 employees · 8 known investors
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
Founders & leadership· Y Combinator alumni (W15)
SM
Shreya MehtainFounder/CTO
JB
John BeckExecutive Officer
ND
Nick DamianoExecutive Officer, Director
BK
Bryan KimDirector
RW
Robert WeisskoffDirector
BR
Blayne RoederDirector
SS
Susan StimsonDirector
RC
Radu CautisDirector
AC
Andrew CleelandDirector
Investors · 8
AstiaSilicon Valley
ShangBay Capital LLCPalo Alto
Y CombinatorSan Francisco · $500K
Dorm RoomreportedBrooklyn · $90K – $250K
F-Prime Capitalreported
F-Prime Capital PartnersreportedCambridge · $3M – $10Mvia Robert Weisskoff · board
Golden SeedsreportedFlushing · $250K – $2M
Medical Technology Venture PartnersreportedSan Francisco
Competitors · 10
by search overlapFda5 shared keywords
Medflow5 shared keywordsMedFlow is an AI-powered clinical operations platform that automates outpatient care workflows such as scheduling, patient prep, care coordination, and closing care gaps, with bidirectional integration into EHRs like athenaOne, HIEs, labs, and engagement tools. It serves healthcare providers and practices, including primary care and specialty practices, to support population health operations and performance-based reimbursement.
NeuroFlow4 shared keywordsNeuroFlow builds behavioral health integration platforms that identify population behavioral health risk, engage individuals with acuity-specific resources, and give care teams data to make decisions. It serves healthcare organizations and health systems aiming to improve outcomes and lower total cost of care.
Stanford blockchain4 shared keywords
Clearflow4 shared keywords
Cardio Flow3 shared keywords
HeartFlow3 shared keywordsHeartflow develops AI-powered 3D modeling and diagnostic tools for coronary artery disease detection and management, serving clinicians and healthcare teams to optimize patient care pathways.
ResearchGate3 shared keywords
NCT051011873 shared keywords
Zencoder3 shared keywords
Companies competing with Zenflow for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$19.4MraisedNov 2024 · 36 investors · Other Health CareRule 506(b)
▶$19.4MraisedNov 2024 · 36 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Susan StimsonDirector
- Bryan KimDirector
- John BeckExecutive Officer
- Radu CautisDirector
- Andrew CleelandDirector
- Robert WeisskoffDirector
- Blayne RoederDirector
- Shreya MehtaExecutive Officer, Director
- Offering amount
- $25.2M
- Amount sold
- $19.4M
- Minimum investment
- $1
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.4MraisedMay 2021 · 43 investors · Other Health CareRule 506(b)
▶$24.4MraisedMay 2021 · 43 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Shreya MehtaExecutive Officer, Director
- Bryan KimDirector
- Nick DamianoExecutive Officer, Director
- Radu CautisDirector
- Robert WeisskoffDirector
- Andrew CleelandDirector
- Offering amount
- $24.4M
- Amount sold
- $24.4M
- Minimum investment
- $1
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$31.5MraisedDec 2017 · 86 investors · Other Health CareRule 506(b)
▶$31.5MraisedDec 2017 · 86 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Shreya MehtaExecutive Officer, Director
- Bryan KimDirector
- Nicholas DamianoExecutive Officer, Director
- Robert WeisskoffDirector
- Radu CautisDirector
- Offering amount
- $32.2M
- Amount sold
- $31.5M
- Minimum investment
- $1
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Zenflow Announces $24 Million Financing Round to Fund FDA Filing & Commercial Preparationglobenewswire.com · 2024
- Revolutionizing BPH Treatment: Zenflow Raises $24 Million in Series C Funding | Signalbasetrysignalbase.com · 2024
- Zenflow Raises $24M in Series C Financingfinsmes.com · 2024
- Zenflow Raises $31.4M in Series A Fundingglobenewswire.com · 2018
